Do streptokinase antibodies inhibit reperfusion during thrombolytic therapy with streptokinase in acute myocardial infarction?
The present investigation indicates that pre-existing streptokinase antibodies play an important role in reperfusion failure during thrombolytic therapy with streptokinase in acute myocardial infarction. Therefore, the determination of streptokinase antibodies may differentiate between those patients who may benefit from streptokinase treatment and those who should be treated with some other regime.
The difference between entrainment from the apex and base is readily performed and is diagnostic for all AVNRTs and septal APs.